REFERENCE / QUESTIONS
Semaglutide questions, answered from the record
Direct answers drawn from the published trials, each cited where it makes a quantitative claim.
Can semaglutide help fatty liver disease (MASH)?
Yes, with the strongest evidence to date. In the 2025 ESSENCE phase-3 trial of biopsy-confirmed MASH with stage 2-3 fibrosis, once-weekly semaglutide 2.4 mg resolved steatohepatitis without worsening fibrosis in 62.9% of participants versus 34.3% with placebo, and improved fibrosis in 36.8% versus 22.4% [1]. These are histologic, controlled-trial outcomes; a 2025 MASH indication followed.
Will semaglutide reduce belly fat?
It reduces overall body weight, which includes abdominal fat, but trials measure total weight rather than belly fat specifically. In STEP 1, once-weekly subcutaneous semaglutide 2.4 mg produced a mean body-weight change of -14.9% from baseline to week 68 versus -2.4% with placebo [2]. Exploratory analyses also reported reduced waist circumference among broader cardiometabolic improvements.
What is semaglutide?
Semaglutide is an FDA-approved GLP-1 receptor agonist — a 31-amino-acid analogue of the gut hormone GLP-1, sharing about 94% of its sequence and engineered to last roughly a week. It activates GLP-1 receptors to prompt glucose-dependent insulin release, suppress glucagon, slow gastric emptying, and reduce appetite [7]. It is given as a weekly injection or daily tablet.
What is semaglutide used for?
Semaglutide is FDA-approved for type 2 diabetes, chronic weight management, reduction of major adverse cardiovascular events in adults with established cardiovascular disease and overweight or obesity, and — since 2025 — metabolic dysfunction-associated steatohepatitis (MASH) [6]. The supporting record includes STEP 1 for weight [2], SELECT for cardiovascular events [4], FLOW for kidney outcomes [5], and ESSENCE for liver disease [1].
How does semaglutide work?
It activates the GLP-1 receptor. At the pancreas it prompts glucose-dependent insulin secretion and suppresses glucagon; at the stomach it slows emptying; and in the brain it engages appetite circuits. In rodents, semaglutide lowered body weight through distributed central pathways — the area postrema, arcuate nucleus, and parabrachial nucleus — reducing intake without lowering energy expenditure [9].
How does semaglutide work for weight loss?
Its weight effect is primarily central, not just gastric. In rodent work it reached hypothalamic and brainstem appetite circuits, activating satiety (POMC/CART) neurons and inhibiting hunger (NPY/AgRP) neurons to reduce food intake and alter food preference, with no fall in energy expenditure [9]. Clinically, STEP 1 reported a mean -14.9% body-weight change at 68 weeks [2].
What is the semaglutide dosage for weight loss?
In the weight-management trials and label, subcutaneous semaglutide is titrated over weeks — 0.25 mg, then 0.5, 1.0, 1.7, to a 2.4 mg once-weekly maintenance dose — to limit gastrointestinal effects; STEP 1 used 2.4 mg and reported -14.9% mean body-weight change at 68 weeks [2]. This is the documented trial dose, not a recommendation; dosing decisions belong to a prescriber.
How many mg is 40 units of semaglutide?
There is no valid general conversion, and "units" is not how the approved product is labelled or dosed. The approved injection is dosed in milligrams (for example 0.25 to 2.4 mg weekly) via pens calibrated for the manufactured product [2]. "Unit" measurements typically arise with compounded or non-pharmaceutical preparations, which fall outside the approved-product evidence base and carry documented FDA safety concerns.
What is compounded semaglutide?
Compounded semaglutide is semaglutide prepared by a compounding pharmacy rather than the approved manufactured product. It was permitted during a federally declared shortage from roughly 2022 to early 2025; the FDA documented dosing errors, hospitalizations, and products with unverified or non-pharmaceutical ingredients, and the pathway was curtailed once the shortage was declared resolved. It sits outside the trial evidence base summarized here.
What are the side effects of semaglutide?
The dominant effects are gastrointestinal — nausea, vomiting, diarrhea, and constipation — mostly mild-to-moderate and concentrated during dose escalation [20], with nausea in roughly one-third of patients [21]. The record also documents increased gallbladder disease, a boxed thyroid C-cell-tumor warning (unconfirmed in humans [23]), a pancreatitis class warning, and a SUSTAIN-6 retinopathy signal with rapid glycemic correction [3].
How long does it take for semaglutide to work?
Glucose and appetite effects begin within the first weeks, but weight-loss trials measure outcomes over many months. STEP 1 reported its -14.9% mean body-weight change at week 68 [2], and STEP 5 sustained weight loss over two years [13]. Because the drug is titrated slowly, full dosing is typically reached only after several weeks.
How long does semaglutide stay in your system?
A long time, by design. Semaglutide's elimination half-life is approximately one week (commonly cited as about 165-168 hours), so with effectively complete clearance only around five weeks after the last dose [8]. That persistence is why it is dosed once weekly as an injection and why label guidance advises a multi-week interval before a planned pregnancy [27].
What is the half-life of semaglutide?
Approximately one week — commonly cited as about 165-168 hours — for both the subcutaneous and oral formulations. A 2024 systematic review confirms this long elimination half-life supports once-weekly subcutaneous dosing [8]. It results from strong reversible albumin binding via the C18 fatty di-acid side chain plus DPP-4 resistance from the Aib-8 substitution.
Is oral semaglutide as effective as the injection?
They share a mechanism, and a meta-analysis reported oral semaglutide is effective for glycemic control and weight with a class-consistent cardiovascular profile [30]. Higher oral doses (25 and 50 mg) were studied to approach injectable efficacy. The practical catch is absorption: oral bioavailability is only about 0.4-1%, so strict fasted dosing is required for the oral form to work as intended [7].
How long does it take for semaglutide to suppress appetite?
Appetite suppression is often reported within the first week or two, consistent with the drug's mechanism. In rodents, semaglutide reached central appetite circuits — the area postrema and hypothalamic arcuate nucleus — to reduce food intake [9]. Because the dose is titrated up over weeks, many people describe the effect strengthening as the dose increases.
Why am I not losing weight on semaglutide?
Response varies, and trials report averages rather than guarantees: STEP 1's mean was -14.9% at 68 weeks, but individual results ranged widely around that mean [2]. Slow titration means full dosing is reached only after weeks, and weight loss often slows after an early phase. This is general information from the record, not personal medical advice — a prescriber can assess an individual situation.
Does semaglutide make you tired?
Fatigue is reported, especially early and around dose increases, and is often community-linked to eating very little or under-hydration rather than a direct drug effect — anecdotal, not a controlled finding. In the trial record, fatigue is not among the dominant adverse effects, which are gastrointestinal [21]. Pharmacovigilance reporting is likewise dominated by GI events [22].
Is semaglutide a GLP-1?
Yes. Semaglutide is a GLP-1 receptor agonist: a long-acting analogue of glucagon-like peptide-1 that binds and activates the GLP-1 receptor with the same downstream effects as the natural incretin hormone, but engineered to circulate for about a week rather than roughly two minutes [7]. It shares approximately 94% sequence homology with native human GLP-1.
Does semaglutide cause hair loss?
A pharmacovigilance signal for hair loss (alopecia) has been reported with semaglutide and tirzepatide [25], and a dermatology study linked telogen effluvium — reversible diffuse shedding — to the magnitude and rate of weight loss [26]. The signal is most consistent with rapid-weight-loss-associated shedding rather than a direct drug toxicity, and is generally described as temporary.
How fast does semaglutide work?
Metabolic and appetite effects start within weeks, but the headline weight outcomes are measured over many months. STEP 1 reported -14.9% mean body-weight change at week 68 [2]. Slow, deliberate dose titration means the full effect builds over time rather than appearing immediately at the starting dose.
What is the difference between semaglutide and tirzepatide?
Semaglutide activates one receptor (GLP-1); tirzepatide is a dual GIP/GLP-1 receptor agonist. In the SURMOUNT-5 head-to-head trial of adults with obesity, tirzepatide produced greater mean weight loss at 72 weeks (-20.2% vs -13.7%; P<0.001) [18]. Semaglutide, however, carries the larger and longer cardiovascular-outcomes record; the two are distinct, non-interchangeable molecules.
What is the downside of semaglutide?
The main downsides are gastrointestinal intolerance during titration [20], weight regain after stopping — a mean of roughly 11.6 percentage points within a year in the STEP 1 extension [16] — and a loss of some lean (muscle) mass alongside fat [24]. The record also carries increased gallbladder disease and signals under surveillance, set against substantial benefits [21].